Work

The use of serum hCG as a marker of tumor progression and of the response of metastatic urothelial cancer to systemic chemotherapy.

Year: 2013

Type: article

Study design: Case Report

Source: PubMed

Authors: Karen Malkhasyan, Hari A Deshpande, Adebowale J Adeniran, John W Colberg, Daniel P Petrylak

Institutions: Yale New Haven Hospital, Yale Cancer Center, Yale University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2402997465

FWCI:

Cites:

Cited by: 4

Related to: 10